Peripheral blood CD34 percentage was significantly higher in the PI+UCM group compared with that in PI+ICC group [median (IQR) of 1.05 (0.70–1.50) vs. 0.35 (0.2–0.5), p < 0.0001]. This evidence concerns the gene CD34 and intrahepatic cholangiocarcinoma.